Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres

被引:44
作者
Matthews, CB
Jenkins, G
Hilfinger, JM
Davidson, BL
机构
[1] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[2] Therapeut Syst Res Labs Inc, Ann Arbor, MI USA
关键词
gene therapy; polymer encapsulation; biodegradable microspheres; adenovirus;
D O I
10.1038/sj.gt.3300978
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In vivo gene transfer with recombinant adenovirus vectors can be hindered by the immunogenicity of the adenovirus capsid proteins. Previous work showed that formulation of the vector with biodegradable polymers such as poly-lactic-glycolic acid (PLGA), polyethylene glycol (PEG), or lipids, may shield the virus from inhibition by neutralizing antibodies. Formulation of adenovirus in PLGA microspheres also allowed for extended release in vitro. In experiments described here, we found that the surfactant used in the formation of the primary emulsion could significantly improve the overall yield of virus released. We also tested the effects of adding poly-L-lysine to adenovirus before encapsulation with PLGA. Our results show that although PLL did not effect the yield of virus encapsulated or released from the microspheres, it significantly improved the efficiency of gene transfer after release from the polymer.
引用
收藏
页码:1558 / 1564
页数:7
相关论文
共 34 条
  • [1] Poly(lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo
    Beer, SJ
    Matthews, CB
    Stein, CS
    Ross, BD
    Hilfinger, JM
    Davidson, BL
    [J]. GENE THERAPY, 1998, 5 (06) : 740 - 746
  • [2] Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro
    Chillon, M
    Lee, JH
    Fasbender, A
    Welsh, MJ
    [J]. GENE THERAPY, 1998, 5 (07) : 995 - 1002
  • [3] Cleland J L, 1997, Pharm Biotechnol, V10, P1
  • [4] The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres
    Cleland, JL
    Mac, A
    Boyd, B
    Yang, J
    Duenas, ET
    Yeung, D
    Brooks, D
    Hsu, C
    Chu, H
    Mukku, V
    Jones, AJS
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (04) : 420 - 425
  • [5] CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES
    COHEN, S
    YOSHIOKA, T
    LUCARELLI, M
    HWANG, LH
    LANGER, R
    [J]. PHARMACEUTICAL RESEARCH, 1991, 8 (06) : 713 - 720
  • [6] The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method
    Coombes, AGA
    Yeh, MK
    Lavelle, EC
    Davis, SS
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 52 (03) : 311 - 320
  • [7] ADMINISTRATION OF AN ADENOVIRUS CONTAINING THE HUMAN CFTR CDNA TO THE RESPIRATORY-TRACT OF INDIVIDUALS WITH CYSTIC-FIBROSIS
    CRYSTAL, RG
    MCELVANEY, NG
    ROSENFELD, MA
    CHU, CS
    MASTRANGELI, A
    HAY, JG
    BRODY, SL
    JAFFE, HA
    EISSA, NT
    DANEL, C
    [J]. NATURE GENETICS, 1994, 8 (01) : 42 - 51
  • [8] Clinical protocol - Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: A phase I trial
    Eck, SL
    Alavi, JB
    Alavi, A
    Davis, A
    Hackney, D
    Judy, K
    Mollman, J
    Phillips, PC
    Wheeldon, EB
    Wilson, JM
    [J]. HUMAN GENE THERAPY, 1996, 7 (12) : 1465 - 1482
  • [9] Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo
    Fasbender, A
    Zabner, J
    Chillon, M
    Moninger, TO
    Puga, AP
    Davidson, BL
    Welsh, MJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) : 6479 - 6489
  • [10] Phase I trial of recombinant adenovirus gene transfer in lung cancer - Longitudinal study of the immune responses to transgene and viral products
    GaherySegard, H
    MolinierFrenkel, V
    LeBoulaire, C
    Saulnier, P
    Opolon, P
    Lengagne, R
    Gautier, E
    LeCesne, A
    Zitvogel, L
    Venet, A
    Schatz, C
    Courtney, M
    LeChevalier, T
    Tursz, T
    Guillet, JG
    Farace, F
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) : 2218 - 2226